| abstract |
The present invention provides a vaccine for use in the treatment of diseases in neonates and / or infants preferably exhibiting an age of 2 years or less, preferably 1 year or less, more preferably 9 months or less or even 6 months or less. The vaccine comprises at least one mRNA encoding at least one antigen, the treatment comprising vaccination of a newborn or an infant, wherein the vaccine elicits an immune response in the newborn or an infant. A vaccine, wherein the induction of an epidemic response in a neonate or infants elicits a Th1 immune response. Furthermore, kits and kits of parts comprising such a vaccine and its components, and methods of applying such a vaccine or kit. 【Selection chart】 None |